- Home
- ENSC vs SYTA Comparison
ENSC vs SYTA Comparison
Compare ENSC & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- SYTA
- Stock Information
- Founded
- ENSC 2003
- SYTA N/A
- Country
- ENSC United States
- SYTA Canada
- Employees
- ENSC N/A
- SYTA N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- SYTA Telecommunications Equipment
- Sector
- ENSC Health Care
- SYTA Telecommunications
- Exchange
- ENSC Nasdaq
- SYTA Nasdaq
- Market Cap
- ENSC 3.4M
- SYTA 3.1M
- IPO Year
- ENSC N/A
- SYTA 2020
- Fundamental
- Price
- ENSC $2.34
- SYTA $2.31
- Analyst Decision
- ENSC
- SYTA
- Analyst Count
- ENSC 0
- SYTA 0
- Target Price
- ENSC N/A
- SYTA N/A
- AVG Volume (30 Days)
- ENSC 5.0M
- SYTA 9.5M
- Earning Date
- ENSC 05-13-2025
- SYTA 05-27-2025
- Dividend Yield
- ENSC N/A
- SYTA N/A
- EPS Growth
- ENSC N/A
- SYTA N/A
- EPS
- ENSC N/A
- SYTA N/A
- Revenue
- ENSC $6,224,081.00
- SYTA $11,740,024.00
- Revenue This Year
- ENSC N/A
- SYTA $14.02
- Revenue Next Year
- ENSC N/A
- SYTA N/A
- P/E Ratio
- ENSC N/A
- SYTA N/A
- Revenue Growth
- ENSC 256.35
- SYTA 41.25
- 52 Week Low
- ENSC $1.62
- SYTA $1.00
- 52 Week High
- ENSC $14.67
- SYTA $885.60
- Technical
- Relative Strength Index (RSI)
- ENSC 46.40
- SYTA 66.79
- Support Level
- ENSC $1.99
- SYTA $1.10
- Resistance Level
- ENSC $2.40
- SYTA $2.00
- Average True Range (ATR)
- ENSC 0.26
- SYTA 0.30
- MACD
- ENSC 0.02
- SYTA 0.13
- Stochastic Oscillator
- ENSC 28.00
- SYTA 60.79
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.